tezepelumab

Italy

Drugs containing this active substance

  • TEZSPIRE

    It is used, together with other medicines, for the treatment of severe asthma in adults and adolescents (from 12 years of age onwards) that is not controlled by usual medications. It is also indicated for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adults.

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    tezepelumab -

    ATC: R03DX11

    Manufacturer: ASTRAZENECA AB